Literature DB >> 17914108

MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle.

Rosa Visone1, Lucia Russo, Pierlorenzo Pallante, Ivana De Martino, Angelo Ferraro, Vincenza Leone, Eleonora Borbone, Fabio Petrocca, Hansjuerg Alder, Carlo Maria Croce, Alfredo Fusco.   

Abstract

We have recently reported that MicroRNAs (miR)-221 and miR-222 were up-regulated in human thyroid papillary carcinomas in comparison with the normal thyroid tissue. Bioinformatic analysis proposed the p27(Kip1) protein, a key regulator of cell cycle, as a candidate target for the miR-221/222 cluster. Here, we report that the enforced expression of miR-221 and miR-222 was able to reduce p27(Kip1) protein levels in thyroid carcinoma and HeLa cells in the absence of significant changes in specific p27(Kip1) mRNA levels. This effect is direct as miR-221 and miR-222 negatively regulate the expression of the 3'-untranslated region-based reporter construct from the p27(Kip1) gene, and is dependent on two target sites in this region. Consistent with these results, an enforced expression of the miR-221 and miR-222 induced the thyroid papillary carcinoma cell line (TPC-1) to progress to the S phase of the cell cycle. It is likely that the negative regulation of p27(Kip1) by miR-221 and miR-222 might also have a role in vivo since we report an inverse correlation between miR-221 and miR-222 up-regulation and down-regulation of the p27(Kip1) protein levels in human thyroid papillary carcinomas. Therefore, the data reported here demonstrate that miR-221 and miR-222 are endogenous regulators of p27(Kip1) protein expression, and thereby, the cell cycle.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17914108     DOI: 10.1677/ERC-07-0129

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  179 in total

1.  MicroRNA-221 inhibits CDKN1C/p57 expression in human colorectal carcinoma.

Authors:  Kai Sun; Wei Wang; Jun-jie Zeng; Cheng-tang Wu; Shang-tong Lei; Guo-xin Li
Journal:  Acta Pharmacol Sin       Date:  2011-01-31       Impact factor: 6.150

2.  Genome-wide screen for miRNA targets using the MISSION target ID library.

Authors:  Matthew J Coussens; Kevin Forbes; Carol Kreader; Jack Sago; Carrie Cupp; John Swarthout
Journal:  J Vis Exp       Date:  2012-04-06       Impact factor: 1.355

3.  Multiple E2F-induced microRNAs prevent replicative stress in response to mitogenic signaling.

Authors:  María J Bueno; Marta Gómez de Cedrón; Usua Laresgoiti; José Fernández-Piqueras; Ana M Zubiaga; Marcos Malumbres
Journal:  Mol Cell Biol       Date:  2010-04-19       Impact factor: 4.272

4.  Identification of microRNAs that mediate thyroid cell growth induced by TSH.

Authors:  Takeshi Akama; Mariko Sue; Akira Kawashima; Huhehasi Wu; Kazunari Tanigawa; Sayuri Suzuki; Moyuru Hayashi; Aya Yoshihara; Yuko Ishido; Norihisa Ishii; Koichi Suzuki
Journal:  Mol Endocrinol       Date:  2012-02-02

5.  MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells.

Authors:  Hong-Ming Song; Yi Luo; Deng-Feng Li; Chuan-Kui Wei; Kai-Yao Hua; Jia-Lu Song; Hui Xu; Niraj Maskey; Lin Fang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

6.  Elevated expression of tumor miR-222 in pancreatic cancer is associated with Ki67 and poor prognosis.

Authors:  ChongLek Lee; Hang He; Yongjian Jiang; Yang Di; Feng Yang; Ji Li; Chen Jin; Deliang Fu
Journal:  Med Oncol       Date:  2013-09-13       Impact factor: 3.064

7.  miR-221 silencing blocks hepatocellular carcinoma and promotes survival.

Authors:  Jong-Kook Park; Takayuki Kogure; Gerard J Nuovo; Jinmai Jiang; Lei He; Ji Hye Kim; Mitch A Phelps; Tracey L Papenfuss; Carlo M Croce; Tushar Patel; Thomas D Schmittgen
Journal:  Cancer Res       Date:  2011-10-18       Impact factor: 12.701

8.  MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer.

Authors:  Menno R Vriens; Julie Weng; Insoo Suh; Nhung Huynh; Marlon A Guerrero; Wen T Shen; Quan-Yang Duh; Orlo H Clark; Electron Kebebew
Journal:  Cancer       Date:  2011-10-17       Impact factor: 6.860

9.  Upregulation of mir-221 and mir-222 in atypical teratoid/rhabdoid tumors: potential therapeutic targets.

Authors:  Simone Treiger Sredni; Maria de Fátima Bonaldo; Fabrício Falconi Costa; Chiang-Ching Huang; Christopher Allan Hamm; Veena Rajaram; Tadanori Tomita; Stewart Goldman; Jared Marshall Bischof; Marcelo Bento Soares
Journal:  Childs Nerv Syst       Date:  2009-12-10       Impact factor: 1.475

10.  Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship.

Authors:  Hyunsoo Kim; Wei Huang; Xiuli Jiang; Brenton Pennicooke; Peter J Park; Mark D Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.